355 filings
S-1
TCON
TRACON Pharmaceuticals Inc
IPO registration
12 Apr 24
4:52pm
8-K
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Results of Operations and Financial Condition
4:43pm
424B5
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Prospectus supplement for primary offering
4:36pm
8-K
TCON
TRACON Pharmaceuticals Inc
10 Apr 24
Other Events
8:05am
8-K
TCON
TRACON Pharmaceuticals Inc
8 Apr 24
TRACON Pharmaceuticals Announces Reverse Stock Split
9:15am
8-K
6474unko
3 Apr 24
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024
8:05am
S-8
sgju9hcbgjm6v kchc5
7 Mar 24
Registration of securities for employees
5:03pm
8-K
4fswk3qn4h9 p7
5 Mar 24
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
nk712f7yxm b8tdv7
19 Dec 23
Other Events
5:00pm
8-K
zzb41sx4u7uhhi8
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
eq3sqs
20 Nov 23
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
8:05am
8-K
se8zy9
9 Nov 23
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
md3bfxkozt
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
i4vt1bo789t9tthax32
18 Sep 23
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
8:10am
8-K
2f3ozk h6jfy
7 Sep 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
goqww wqa
14 Aug 23
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:12pm